Isracann Biosciences Inc. (OTCPK:ISCNF) (CSE:IPOT) (XFRA:A2PT0E) has facilitated its first shipment of cannabis strains to Israel.

The agreement for genetics is directly between United Greeneries Ltd, a licensed Canadian producer of craft cannabis, and Intelicanna, a licensed Israeli medical cannabis grower and brand. Three initial strains are included in the agreement, with the provision for additional strains. Under a revenue sharing agreement, United Greeneries shall be responsible for cultivation and genetics support, with in-country support provided by Isracann.

“Israel is the largest importer of Canadian cannabis in the world,” stated CEO Phil Floucault. “The primary …

Full story available on Benzinga.com